Palonosetron improves prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy: results of a double-blind randomized phase III trial comparing single doses of palonosetron with ondansetron-Reference-Cited by-同舟云学术

Palonosetron improves prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy: results of a double-blind randomized phase III trial comparing single doses of palonosetron with ondansetron

Published:2003-10 Issue:10 Volume:14 Page:1570-1577
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Gralla R.,Lichinitser M.,Van der Vegt S.,Sleeboom H.,Mezger J.,Peschel C.,Tonini G.,Labianca R.,Macciocchi A.,Aapro M.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/14/10/1570/420027/mdg417.pdf

Reference30 articles.

1. Granisetron, tropisetron, and ondansetron in the prevention of acute emesis induced by a combination of cisplatin–adriamycin and by high-dose ifosfamide delivered in multi-day continuous infusions;Forni;Support Care Cancer,2000

2. Recommendations for the use of antiemetics: evidence-based, clinical practice guidelines;Gralla;J Clin Oncol,1999

3. Antiemetic guidelines: creating a more practical approach;Koeller;Support Care Cancer,2002

4. The development of a protocol for the use of 5-HT3 antagonists in chemotherapy-induced nausea and vomiting;Watters;Clin Oncol,2001

5. Advances in use of the 5-HT3 receptor antagonists;Walton;Exp Opin Pharmacother,2000

Cited by 393 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dexamethasone-sparing strategies in anthracycline and cyclophosphamide-based chemotherapy with a focus on 5-HT3 receptor antagonists: a network meta-analysis;Frontiers in Oncology;2024-07-26

2. Real hopes in antiemetic therapy;Meditsinskiy sovet = Medical Council;2024-07-25

3. Biological activities of selected 1-Oxo-tetrahydroisoquinolinone alkaloids;Natural Product Research;2024-07-19

4. Bibliometric and visual analysis of chemotherapy-induced nausea and vomiting (2004-2023);Frontiers in Oncology;2024-04-24

5. Effect of Selective 5-Hydroxytryptamine-3 Receptor and Neurokinin-1 Receptor Antagonists on Hemodynamic Changes and Arrhythmogenic Potential in Patients Receiving Chemotherapy: A Retrospective, Observational Study;Journal of Clinical Medicine;2024-02-01